Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation

Renal Failure

Volumn 30, Issue 6, 2008, Pages 611-616

  Tang, Zheng ^a,b   Ji, Shu Ming ^a   Chen, Dong Rui ^a   Wen, Ji Qiu ^a   Chen, Jin Song ^a   Liu, Zhi Hong ^a   Li, Lei Shi ^a  

^a NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

Crescent; Kidney transplantation; Recurrent IgA nephropathy

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; IMMUNOGLOBULIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; AGED; ARTICLE; CADAVER; CELL PROLIFERATION; CHINESE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; EDEMA; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEMATURIA; HEMODIALYSIS; HOSPITAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MESANGIUM CELL; NEPHROLOGY; PATHOLOGY; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; SAMPLE; UNIVERSITY;

ADULT; AGE DISTRIBUTION; AGED; BIOPSY; CHINA; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS, IGA; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RENAL DIALYSIS; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 48149089009     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802134516     Document Type: Article

References (21)

1. Li LS, Guan TJ, Liu ZH, Zeng CH, Tang Z. Demographic investigation of glomerular diseases in Chinese adults. J Nephrol Dialy Transplant. 1997; 6(2):103-107.
2. Chen HP, Zeng CH, Hu WX, Tang Z, Liu ZH, Li LS. Analysis of 10594 renal biopsy data. J Nephrol Dialy Transplant. 2000;9(6):501-508.
3. Tang Z, Li LS, Zhang JH, Yu YS, Wang QW, Jiang W. Clinical and pathological features in IgA nephropathy patients with crescentic formation. Chin J Nephrol. 1993;9:80-84.
4. Ji SM, Tang Z, Chen JS, Chen HP, Liu ZH, Li LS. Clinical and pathological spectrums of recurrent IgA nephropathy after renal transplantation. In press.
5. Wang AY, Lai FM, Yu AW, Lam PK, Chow KM, Choi PC, Lui SF, Li PK. Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis, 2001;38:588-596.
6. Ramos EL, Tisher CC. Recurrent diseases in the renal transplant. Am J Kidney Dis. 1994;24(1):142-154.
7. Ponticelli C, Traversi L, Feliciani A, Cesana BM, Banfi G, Tarantino A. Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int. 2001;60:1948-1954.
8. Floege J. Recurrent IgA nephropathy after renal transplantation. Sem Nephrology. 2004;24(3):287-291.
9. Diaz-Tejeiro R, Maduell F, Diez J, et al. Loss or graft due to recurrent IgA nephropathy with rapidly progressive course: An unusual clinical evolution. Nephron. 1990;54:341-344.
10. Streather CP, Scoble JE. Recurrent IgA nephropathy in a renal allograft presenting as crescentic glomerulonephritis. Nephron. 1994;66:113-114.
11. Kimata N, Tanabe K, Ishikawa N, et al. Correlation between proteinuria and prognosis of transplant IgA nephropathy. Transplant Proc. 1996;28:1537-1539.
12. Kowalewska J, Yuan S, Sustento-Reodica N, et al. IgA nephropathy with crescents in kidney transplant recipients. Am J Kidney Dis. 2005;45(1):167-175.
13. Churg J, Bernstein J Glassock R. Renal Disease Classification and Atlas of Glomerular Diseases. 2nd ed. New York: Igaku-Shoin; 1995:134-135.
14. Schwarz A, Kraus P-H, Offerman G, et al. Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis. 1991;17:524-531.
15. Berger J, Yaneya H, Nabarra B, et al. Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int. 1975;7:232-241.
16. Nowack R, Birck R, van der Woude FJ. Mycophenolate mofetil for systemic vasculitis and IgA nephritits. Lancet. 1997;349:774.
17. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanism of action. Immunopharmacology. 2000;47:85-94.
18. Ziswiler R, Steinmann-Niggli K, Kappeler A, Daniel C, Marti HP. A new approach to the therapy of experimental mesangial proliferative glomerulonephritis. J Am Soc Nephrol. 1998;9:2055-2066.
19. Hu WX, Chen X, Yao XD, Tang Z, Liu ZH, Li LS. Clinical trial of mycophenolate mofetil therapy for renal lesions in patients with small vasculitis. J Nephrol Dialy Transplant. 2002;11(2):110-115.
20. Chan TM, Li FK, Tang CS. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol. 2005;16:1078-1084.
21. Chen X, Chen P, Cai G. A randomized controlled trial of mycophenolate mofetial treatment in severe IgA nephropathy. Zhonghua Yi Xue Za Zhi. 2002;82:796-801.